Investigators at University of Chicago Discuss Findings in CDC and FDA (Conformalized Survival Analysis).

Researchers at the University of Chicago have developed a new method for predicting survival times based on conformal prediction. This method produces lower predictive bounds on survival times that are calibrated and dependent on covariates. The researchers demonstrated the validity and efficiency of their procedure using synthetic data and real COVID-19 data from the UK Biobank. This research has been peer-reviewed and can be found in the Journal of the Royal Statistical Society Series B (Statistical Methodology). [Extracted from the article]